Alnylam Pharmaceuticals
ALNY
#459
Rank
HK$410.13 B
Marketcap
HK$3,104
Share price
-0.28%
Change (1 day)
54.38%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company